e-Appendix 1.
Subjects: we here extended our investigation of the same 25 non-smokers reported previously. 2 Those were human RV16 neutralizing antibody sero-negative and comprised of: 10 atopic asthmatics and 15 normal non atopic adults (Table 1) .
Clinical and atopic status were defined by questionnaire, skin prick testing, serum IgE and lung function testing including PEF, FEV 1 , forced vital capacity (FVC). 2 The normal healthy subjects were taking no medication. Asthmatics were prescribed inhaled short-acting β 2 -agonists only. Subjects were free of common cold symptoms for at least 6 weeks prior to the study start.
Histamine challenge. Bronchial reactivity was measured by histamine challenge at baseline, on day 6 after infection and convalescence. For bronchodilator reversibility, sputum induction and histamine challenge subjects used a Vitalograph Dry Wedge Bellows Spirometer. Histamine challenge (maximum concentration 32 mg/ml) was performed according to guidelines by using the 2-min tidal breathing method. 1 The asthmatic group was required to have a PC20 < 8 mg/ml, and the normal group had > 8 mg/ml. The provocative concentration of histamine causing a 20% reduction in FEV1 (PC20) was 4
Statistical analysis
Statistical analysis was performed using StatView (SAS Institute. Inc) and GraphPad Prism 4 (GraphPad Software, Inc) softwares.
One way ANOVA followed by the unpaired Student's t-test was used for the analyses of age, serum IgE, lung function and histamine PC 20 data between groups. In respect of cell counts, these data were non-normally distributed and differences between groups were assessed first using the Kruskal-Wallis test, which, if significant, was followed by Wilcoxon matched pairs test within group between baseline and infection and
Mann-Whitney U-test between groups at baseline and infection. The coefficient of variation (CV = SD/mean × 100) was used to express the error of repeat counts. A P-value of < 0.05 was accepted as indicating a significant difference. Spearman's rank correlation was used as a test for correlations between the numbers of specific types of inflammatory cell and physiologic/clinical data. We wished to examine the relationships between virus load and the inflammatory response and believe that this is relevant in the non-asthmatic subjects also.
Including the controls allowed us to examine these relationships in greater numbers of subjects and therefore avoid the possibility of missing significant correlations due to lack of power.
